Skip to content
value.today
Rezolute, Inc. logo

Rezolute, Inc.

RZLT
$398 Mmarket cap on Oct 28, 2026+893.8% since Jan 2024
Compare
World rank
#13,576
Revenue
—
For year ending June-2026
Net income
$-78 M
SEC filing
Employees
58
As of June 30, 2026
SEC filing

Rezolute, Inc. in brief

Rezolute, Inc. is a listed company in the Biotechnology industry, based in Redwood City, California, USA. Its market value was $398 M on 28 October 2026, which makes it the 13,576th largest listed company in the world and the 2,669th largest in the USA on this site. It employs about 58 people and Nevan C. Elam is its chief executive. Its shares trade under the symbol RZLT (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Rezolute, Inc.

Rezolute, Inc. is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism.

Ersodetug is an intravenously administered human monoclonal antibody that binds to a unique site (allosteric) on the insulin receptor in insulin target tissues, such as in the liver, fat, and muscle. The antibody down modulates insulin receptor activity, thereby helping to restore glucose to a more normalized range in conditions associated with elevated insulin or insulin-like substances (e.g. IGF-2 variants). Ersodetug shows dose dependent pharmacokinetics with a half-life greater than 2 weeks, which has the potential for monthly dosing. Therefore, we believe that ersodetug is ideally suited as a potential therapy for conditions characterized by HI, and it is being developed to treat any form of HI. As ersodetug acts downstream from the cause of disease and source of HI (insulin or IGF-2 production), it has the potential to be universally effective at treating hypoglycemia related to HI, whether genetic or acquired.

From the company's annual report filed with the US SEC: read the report

Rezolute, Inc. timeline

3 events, 2011–2017
  1. 2011
  2. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  3. 2013
  4. ✎
    Renamed AntriaBio, Inc.
    Formerly Fits My Style Inc.
  5. 2017
  6. ✎
    Renamed Rezolute, Inc.
    Formerly AntriaBio, Inc..

Events of Rezolute, Inc. from SEC EDGAR. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$127 M$254 M$382 M$509 M2023202420252026

World rank over time

▲ up 11,326 places since 2022
2022-01-07: #24929#24,92920222022-12-25: #22995#22,99520222023-07-30: #23648#23,64820232024-01-05: #26020#26,02020242026-03-08: #8343#8,34320262026-08-01: #12753#12,75320262026-10-13: #12905#12,90520262026-10-28: #13603#13,6032026

Rank in USA: #4,689 (Jan 2022) · #4,478 (Dec 2022) · #4,524 (Jul 2023) · #4,161 (Jan 2024) · #1,530 (Mar 2026) · #2,608 (Aug 2026) · #2,563 (Oct 2026) · #2,672 (Oct 2026)

Key ratios

market cap and latest results
P/E ratio
n/m (loss)
Price / sales
—
Price / book
3.9×
Free cash flow yield
-11.2%
Net margin
—
Operating margin
—
Return on equity
-77.1%
Liabilities / assets
10.8%
Net debt
$-27M
Profit per employee
$-1.3 M

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Jun 2019: revenue —, net income $-30M—FY19Fiscal year ending Jun 2020: revenue —, net income $-20M—FY20Fiscal year ending Jun 2021: revenue —, net income $-21M—FY21Fiscal year ending Jun 2022: revenue —, net income $-41M—FY22Fiscal year ending Jun 2023: revenue —, net income $-52M—FY23Fiscal year ending Jun 2024: revenue —, net income $-68M—FY24Fiscal year ending Jun 2025: revenue —, net income $-74M—FY25Fiscal year ending Jun 2026: revenue —, net income $-78M—FY26
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Jun 2026——$-83M$-78M—
Jun 2025——$-80M$-74M—
Jun 2024——$-70M$-68M—
Jun 2023——$-56M$-52M—
Jun 2022——$-42M$-41M—
Jun 2021——$-23M$-21M—
Jun 2020——$-21M$-20M—
Jun 2019——$-26M$-30M—

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Jun 2026$-65M——$-0.75—
Jun 2025$-69M——$-0.98—
Jun 2024$-57M——$-1.33—
Jun 2023$-44M$0M$-45M$-1.01—
Jun 2022$-40M——$-2.32—
Jun 2021$-20M——$-2.72—
Jun 2020$-24M$0M$-24M$-3.54—
Jun 2019$-15M$0M$-15M$-18.41—

Quarterly results

USD · three months to · source: SEC filings
RevenueNet income
Three months to Dec 2024: revenue —, net income $-16M—Dec ’24Three months to Mar 2025: revenue —, net income $-19M—Mar ’25Three months to Jun 2025 (from the annual report): revenue —, net income $-24M—Jun ’25Three months to Sep 2025: revenue —, net income $-18M—Sep ’25Three months to Dec 2025: revenue —, net income $-23M—Dec ’25Three months to Mar 2026: revenue —, net income $-16M—Mar ’26Three months to Jun 2026 (from the annual report): revenue —, net income $-21M—Jun ’26Three months to Sep 2026: revenue —, net income $-18M—Sep ’26

Latest quarter to Sep 2026: revenue —, net income $-18M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.

SEC filings

Official filings of Rezolute, Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
—
Operating income
$-83 M
Net income
$-78 M

For year ending June-2026 · source: SEC filing

Balance sheet

Total assets
$113 M
Total liabilities
$12 M
Total equity
$101 M

As of June-2026

Top 100 institutional investors in Rezolute, Inc.#

As of Sep 30, 2026
137 institutions held 84.9 M shares (about 87.8% of the shares outstanding) on Sep 30, 2026. The ten largest hold 57.3%. Source: SEC Form 13F filings, filed through Nov 18, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in Rezolute, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1Federated Hermes, Inc.12,948,522-42,137 (-0.32%)13.39%$54 MNov 12, 2026
2Ra Capital Management, L.P.9,445,0390 (0.00%)9.77%$39 MNov 16, 2026
3BlackRock, Inc.8,271,734+553,443 (+7.17%)8.55%$34 MNov 13, 2026
4Jennison Associates LLC5,332,068+2,872,760 (+116.81%)5.51%$22 MNov 16, 2026
5Opaleye Management Inc.4,087,045-2,212,955 (-35.13%)4.23%$17 MNov 16, 2026
6Balyasny Asset Management L.P.3,765,882-896,157 (-19.22%)3.89%$16 MNov 16, 2026
7Vanguard Capital Management LLC3,718,321-117,506 (-3.06%)3.84%$15 MNov 13, 2026
8Siren, L.L.C.3,328,2870 (0.00%)3.44%$14 MNov 12, 2026
9D. E. Shaw & Co., Inc.2,388,933+549,576 (+29.88%)2.47%$10 MNov 16, 2026
10Geode Capital Management, LLC2,133,521-36,633 (-1.69%)2.21%$9 MNov 6, 2026
11State Street Corp1,829,128-21,000 (-1.14%)1.89%$8 MNov 12, 2026
12Kennedy Capital Management LLC1,670,496+448,818 (+36.74%)1.73%$7 MNov 13, 2026
13Vestal Point Capital, LP1,455,000+1,072,001 (+279.90%)1.50%$6 MNov 16, 2026
14Millennium Management LLC1,355,643+838,409 (+162.09%)1.40%$6 MNov 16, 2026
15Vanguard Portfolio Management LLC1,279,413-101,333 (-7.34%)1.32%$5 MNov 13, 2026
16Affinity Asset Advisors, LLC1,000,0000 (0.00%)1.03%$4 MNov 13, 2026
17Dimensional Fund Advisors LP991,935+101,202 (+11.36%)1.03%$4 MNov 4, 2026
18Schonfeld Strategic Advisors LLC979,923+716,177 (+271.54%)1.01%$4 MNov 16, 2026
19Great Point Partners LLC951,8090 (0.00%)0.98%$4 MNov 16, 2026
20AQR Capital Management LLC940,487-67,475 (-6.69%)0.97%$4 MNov 16, 2026
21Ikarian Capital, LLC935,0120 (0.00%)0.97%$4 MNov 16, 2026
22Blue Owl Capital Holdings LP935,000New0.97%$4 MNov 13, 2026
23Jacobs Levy Equity Management, Inc932,188-1,629,466 (-63.61%)0.96%$4 MNov 16, 2026
24Goldman Sachs Group Inc886,418-430,364 (-32.68%)0.92%$4 MNov 16, 2026
25Charles Schwab Investment Management Inc720,670-2,918 (-0.40%)0.75%$3 MNov 16, 2026
Show all 100: investors 26 to 100
Institutional investors 26 to 100 in Rezolute, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
26Two Sigma Investments, LP711,437+280,364 (+65.04%)0.74%$3 MNov 16, 2026
27Northern Trust Corp697,478-27,793 (-3.83%)0.72%$3 MNov 16, 2026
28Driehaus Capital Management LLC697,238+407,719 (+140.83%)0.72%$3 MNov 16, 2026
29Woodline Partners LP611,7970 (0.00%)0.63%$3 MNov 16, 2026
30Citadel Advisors LLC584,138+485,648 (+493.09%)0.60%$2 MNov 16, 2026
31Vanguard Fiduciary Trust Co524,322-46,715 (-8.18%)0.54%$2 MNov 13, 2026
32FMR LLC454,404+238,287 (+110.26%)0.47%$2 MNov 10, 2026
33Gsa Capital Partners LLP420,961New0.44%$2 MNov 16, 2026
34J. Goldman & Co LP407,036-93,369 (-18.66%)0.42%$2 MNov 16, 2026
35Barclays PLC376,581+220,192 (+140.80%)0.39%$2 MNov 6, 2026
36Janus Henderson Group Ltd.339,704—0.35%$1 MNov 16, 2026
37XTX Topco Ltd331,148-22,522 (-6.37%)0.34%$1 MNov 16, 2026
38Jane Street Group, LLC321,828+57,949 (+21.96%)0.33%$1 MNov 12, 2026
39Morgan Stanley288,834-1,329,949 (-82.16%)0.30%$1 MNov 13, 2026
40Boothbay Fund Management, LLC286,9550 (0.00%)0.30%$1 MNov 16, 2026
41Susquehanna Portfolio Strategies, LLC279,6410 (0.00%)0.29%$1 MNov 16, 2026
42Wellington Management Group LLP278,900+225,873 (+425.96%)0.29%$1 MNov 16, 2026
43Russell Investments Group, Ltd.259,307+49,263 (+23.45%)0.27%$1 MNov 6, 2026
44Los Angeles Capital Management LLC242,065+164,242 (+211.05%)0.25%$1 MNov 12, 2026
45HRT Financial LP230,102New0.24%$1 MNov 13, 2026
46Bank of New York Mellon Corp223,058+10,788 (+5.08%)0.23%$1 MNov 5, 2026
47ExodusPoint Capital Management, LP217,813New0.23%$1 MNov 16, 2026
48Jump Financial, LLC217,200New0.22%$1 MNov 13, 2026
49Nuveen, LLC203,260-1,091,949 (-84.31%)0.21%$1 MNov 10, 2026
50Knott David M Jr159,638-210,362 (-56.85%)0.17%$1 MNov 12, 2026
51Creative Planning157,124+39,762 (+33.88%)0.16%$1 MNov 2, 2026
52Jpmorgan Chase & Co151,772+116,017 (+324.48%)0.16%$1 MNov 12, 2026
53Group One Trading LLC150,555-1,427 (-0.94%)0.16%$1 MNov 10, 2026
54ADAR1 Capital Management, LLC148,679+100,000 (+205.43%)0.15%$1 MNov 16, 2026
55Weiss Asset Management LP145,438New0.15%$1 MNov 16, 2026
56UBS Group AG138,847-357,186 (-72.01%)0.14%$1 MNov 10, 2026
57Squarepoint Ops LLC134,984New0.14%$1 MNov 9, 2026
58Simplex Trading, LLC130,753+29,510 (+29.15%)0.14%$1 MNov 4, 2026
59Alps Advisors Inc126,671+28,947 (+29.62%)0.13%$1 MNov 3, 2026
60Pavaki Capital Management LLC120,0000 (0.00%)0.12%$0 MOct 26, 2026
61SEI Investments Co106,462+12,987 (+13.89%)0.11%$0 MNov 10, 2026
62Bank Of America Corp /de/105,518-624,814 (-85.55%)0.11%$0 MNov 16, 2026
63State Of Wisconsin Investment Board102,598New0.11%$0 MNov 16, 2026
64Rhumbline Advisers92,541-1,757 (-1.86%)0.10%$0 MNov 10, 2026
65Virtus Investment Advisers, LLC79,333-2,467 (-3.02%)0.08%$0 MNov 12, 2026
66AlphaCentric Advisors LLC75,495+3,240 (+4.48%)0.08%$0 MNov 3, 2026
67HSBC Holdings PLC72,004+18,407 (+34.34%)0.07%$0 MNov 16, 2026
68Deutsche Bank AG\71,197-9,583 (-11.86%)0.07%$0 MNov 6, 2026
69Marshall Wace, LLP69,955-5,884 (-7.76%)0.07%$0 MNov 13, 2026
70Acadian Asset Management LLC69,611-518 (-0.74%)0.07%$0 MNov 9, 2026
71Alliancebernstein L.P.68,2800 (0.00%)0.07%$0 MNov 16, 2026
72Price T Rowe Associates Inc /MD/64,895+1,287 (+2.02%)0.07%$0 MNov 16, 2026
73BNP Paribas Financial Markets63,905+48,625 (+318.23%)0.07%$0 MNov 12, 2026
74Birchview Capital, LP60,296New0.06%$0 MNov 13, 2026
75Mariner, LLC52,130-9,635 (-15.60%)0.05%$0 MNov 12, 2026
76MetLife Investment Management, LLC47,2070 (0.00%)0.05%$0 MNov 16, 2026
77Canada Pension Plan Investment Board45,700+6,200 (+15.70%)0.05%$0 MNov 16, 2026
78WINTON GROUP Ltd43,400+26,400 (+155.29%)0.04%$0 MNov 12, 2026
79MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.37,984+1,943 (+5.39%)0.04%$0 MNov 16, 2026
80Invesco Ltd.37,888-2,787 (-6.85%)0.04%$0 MNov 12, 2026
81Mercer Global Advisors Inc /adv34,607-991 (-2.78%)0.04%$0 MNov 16, 2026
82American Century Companies Inc33,330+8,333 (+33.34%)0.03%$0 MNov 12, 2026
83Vanguard Global Advisers, LLC28,469-6,714 (-19.08%)0.03%$0 MNov 13, 2026
84Wealth Enhancement Advisory Services, LLC27,464-7,244 (-20.87%)0.03%$0 MOct 13, 2026
85Integrated Wealth Concepts LLC27,450+6 (+0.02%)0.03%$0 MNov 17, 2026
86Cerity Partners LLC27,353-1,490 (-5.17%)0.03%$0 MNov 13, 2026
87Wells Fargo & Company/mn26,960-40,968 (-60.31%)0.03%$0 MNov 16, 2026
88Susquehanna International Group, LLP24,335New0.03%$0 MNov 16, 2026
89Police & Firemen's Retirement System of New Jersey21,8000 (0.00%)0.02%$0 MNov 9, 2026
90Manufacturers Life Insurance Company, The21,640-276 (-1.26%)0.02%$0 MNov 13, 2026
91Royal Bank Of Canada19,345+16,967 (+713.50%)0.02%$0 MNov 16, 2026
92Nia Impact Advisors, LLC18,322New0.02%$0 MNov 4, 2026
93Voya Investment Management LLC15,1980 (0.00%)0.02%$0 MNov 10, 2026
94New York State Common Retirement Fund15,0000 (0.00%)0.02%$0 MNov 17, 2026
95Captrust Financial Advisors13,550-9,660 (-41.62%)0.01%$0 MNov 12, 2026
96Prudential Financial Inc12,9000 (0.00%)0.01%$0 MNov 16, 2026
97Tower Research Capital LLC (TRC)10,130+5,041 (+99.06%)0.01%$0 MNov 16, 2026
98Brighton Jones LLC10,051-2,669 (-20.98%)0.01%$0 MNov 3, 2026
99Auxano Advisors, LLC10,0000 (0.00%)0.01%$0 MNov 6, 2026
100Arax Advisory Partners8,175-4,179 (-33.83%)0.01%$0 MNov 12, 2026

All 137 institutional investors, with who bought and sold →

Mutual funds holding Rezolute, Inc.#

124 funds hold shares worth $131 M (about 28.6% of the company). Since their previous reports 67 added shares and 35 sold, buying $8 M net.
Mutual funds holding Rezolute, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Federated Hermes Kaufmann FundFederated Advisory Services Company7.48 M$35 M7.7%0.72%no changeJul 31, 2026
🇺🇸 Federated Hermes Kaufmann Small Cap FundFederated Advisory Services Company5.34 M$25 M5.5%0.89%no changeJul 31, 2026
🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.2.74 M$14 M2.8%<0.01%+11%Jun 30, 2026
🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors2.07 M$11 M2.1%0.01%+15%Jun 30, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.1.01 M$5 M1.0%<0.01%+4.2%Jun 30, 2026
🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC856,711$4 M0.89%0.01%+19%Jul 31, 2026
🇺🇸 iShares Russell 2000 Value ETFBlackRock Fund Advisors636,980$3 M0.66%0.02%+603%Jun 30, 2026
🇺🇸 Vanguard Strategic Small-Cap Equity FundThe Vanguard Group, Inc.629,453$3 M0.65%0.10%−36%Jun 30, 2026
🇺🇸 Janus Henderson Small Cap Growth Alpha ETFJanus Henderson Investors US LLC320,855$2 M0.33%0.42%newJul 31, 2026
🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP319,926$2 M0.33%<0.01%+1.8%Jul 31, 2026
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC450,654$1 M0.47%<0.01%+1.1%May 31, 2026
🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors263,185$1 M0.27%0.09%+44%Jun 30, 2026
🇺🇸 Schwab U.S. Small-Cap ETFCharles Schwab Investment Management, Inc.411,571$1 M0.43%<0.01%−1.6%May 31, 2026
🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC239,040$1 M0.25%<0.01%newJun 30, 2026
🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc.372,322$1 M0.38%<0.01%−6.7%May 31, 2026
🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc.190,465$1 M0.20%0.01%+20%Jul 31, 2026
🇺🇸 Federated Hermes Kaufmann Fund IIFederated Advisory Services Company165,799$1 M0.17%0.76%—Jun 30, 2026
🇺🇸 Fidelity Enhanced Small Cap Core ETFFidelity Management & Research Company LLC155,117$1 M0.16%0.01%newJun 30, 2026
🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC155,100$1 M0.16%0.01%+18%Jun 30, 2026
🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP157,858$1 M0.16%<0.01%+63%Jul 31, 2026
🇺🇸 Vanguard U.S. Momentum Factor ETFThe Vanguard Group, Inc.218,828$1 M0.23%0.04%+132%May 31, 2026
🇺🇸 Vanguard Health Care Index FundThe Vanguard Group, Inc.216,528$1 M0.22%<0.01%−0.8%May 31, 2026
🇺🇸 U.S. Micro Cap PortfolioDimensional Fund Advisors LP144,130$1 M0.15%<0.01%+70%Jul 31, 2026
🇺🇸 BlackRock Advantage Small Cap Core FundBlackRock Advisors, LLC196,603$1 M0.20%0.01%newMay 29, 2026
🇺🇸 iShares Core S&P Total U.S. Stock Market ETFBlackRock Fund Advisors119,761$1 M0.12%<0.01%+2.3%Jun 30, 2026
🇺🇸 BlackRock Advantage Small Cap Growth FundBlackRock Funds119,243$1 M0.12%0.07%newJun 30, 2026
🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors97,914$1 M0.10%<0.01%−81%Jun 30, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC152,290$1 M0.16%<0.01%no changeMay 31, 2026
🇺🇸 Fidelity Small Cap Value Index FundFidelity Management & Research Company LLC94,975$0 M0.10%0.02%+618%Jun 30, 2026
🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC104,184$0 M0.11%0.01%+55%Jul 31, 2026
🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC85,528$0 M0.09%0.01%−2.3%Jun 30, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC131,055$0 M0.14%<0.01%+9.2%May 31, 2026
🇺🇸 Goldman Sachs ActiveBeta U.S. Small Cap Equity ETFGoldman Sachs Asset Management, L.P.117,274$0 M0.12%0.04%+1.3%May 31, 2026
🇺🇸 Nuveen Equity Index FundTeachers Advisors, LLC71,353$0 M0.07%<0.01%newJul 31, 2026
🇺🇸 ALPS Medical Breakthroughs ETFALPS Advisors, Inc.98,643$0 M0.10%0.20%+19%May 31, 2026
🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC62,983$0 M0.07%0.03%+326%Jul 31, 2026
🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc.60,257$0 M0.06%<0.01%no changeJul 31, 2026
🇺🇸 VIP Disciplined Small Cap PortfolioFidelity Management & Research Company LLC53,774$0 M0.06%0.04%no changeJun 30, 2026
🇺🇸 PACE Small/Medium Co Growth Equity InvestmentsUBS Asset Management (Americas) LLC56,506$0 M0.06%0.10%+449%Jul 31, 2026
🇺🇸 Goldman Sachs Small Cap Growth Insights FundGoldman Sachs Asset Management, L.P.54,979$0 M0.06%0.08%no changeJul 31, 2026
🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation48,800$0 M0.05%0.01%no changeJun 30, 2026
🇺🇸 NVIT Multi-Manager Small Company FundNATIONWIDE FUND ADVISORS47,300$0 M0.05%0.05%newJun 30, 2026
🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc.47,129$0 M0.05%<0.01%+15%Jun 30, 2026
🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP50,203$0 M0.05%<0.01%+236%Jul 31, 2026
🇺🇸 NVIT Small Cap Value FundNATIONWIDE FUND ADVISORS42,800$0 M0.04%0.10%newJun 30, 2026
🇺🇸 Fidelity ZERO Total Market Index FundFidelity Management & Research Company LLC46,922$0 M0.05%<0.01%−2.7%Jul 31, 2026
🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc.40,520$0 M0.04%0.01%+42%Jun 30, 2026
🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc.38,633$0 M0.04%<0.01%no changeJun 30, 2026
🇺🇸 Goldman Sachs Small Cap Equity Insights FundGoldman Sachs Asset Management, L.P.42,514$0 M0.04%0.02%no changeJul 31, 2026
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC60,127$0 M0.06%<0.01%no changeMay 31, 2026
🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc.58,177$0 M0.06%0.01%−7.6%May 31, 2026
🇺🇸 Diversified Equity Alpha Master PortfolioBlackRock Fund Advisors34,637$0 M0.04%<0.01%+77%Jun 30, 2026
🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC37,404$0 M0.04%0.01%+19%Jul 31, 2026
🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC32,480$0 M0.03%<0.01%+302%Jun 30, 2026
🇺🇸 Small Cap Equity FundGuideStone Capital Management, LLC30,230$0 M0.03%0.02%newJun 30, 2026
🇺🇸 Fidelity ZERO Extended Market Index FundFidelity Management & Research Company LLC31,864$0 M0.03%<0.01%+4.7%Jul 31, 2026
🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC27,730$0 M0.03%<0.01%no changeJun 30, 2026
🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC26,980$0 M0.03%0.01%+5.8%Jun 30, 2026
🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC25,562$0 M0.03%0.01%+1.8%Jun 30, 2026
🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc.25,200$0 M0.03%<0.01%+0.4%Jun 30, 2026
🇺🇸 Small Cap Core FundNorthern Trust Investments, Inc.21,589$0 M0.02%0.03%−4.3%Jun 30, 2026
🇺🇸 Multi-Manager Small Cap Equity Strategies FundColumbia Funds Series Trust I33,579$0 M0.03%<0.01%newMay 31, 2026
🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC20,410$0 M0.02%0.01%no changeJun 30, 2026
🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company28,464$0 M0.03%<0.01%−21%May 31, 2026
🇺🇸 Dimensional US Core Equity Market ETFDimensional Fund Advisors LP19,647$0 M0.02%<0.01%+241%Jul 31, 2026
🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS17,698$0 M0.02%0.01%+19%Jun 30, 2026
🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC17,540$0 M0.02%0.04%+34%Jun 30, 2026
🇺🇸 U.S. Vector Equity PortfolioDimensional Fund Advisors LP19,300$0 M0.02%<0.01%newJul 31, 2026
🇺🇸 AVIP BlackRock Advantage Small Cap Growth PortfolioCONSTELLATION INVESTMENTS INC17,406$0 M0.02%0.06%+127%Jun 30, 2026
🇺🇸 Small Cap Index TrustJohn Hancock Variable Trust Advisers LLC16,363$0 M0.02%0.01%+21%Jun 30, 2026
🇺🇸 JNL/DFA U.S. Small Cap FundJackson National Asset Management, LLC14,691$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 Goldman Sachs Variable Insurance Trust Small Cap Equity Insights FundGoldman Sachs Asset Management, L.P.14,491$0 M0.01%0.03%newJun 30, 2026
🇺🇸 U.S. Sustainability Core 1 PortfolioDimensional Fund Advisors LP15,887$0 M0.02%<0.01%no changeJul 31, 2026
🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P.14,320$0 M0.01%<0.01%+30%Jun 30, 2026
🇺🇸 NVIT GS Small Cap Equity Insights FundNATIONWIDE FUND ADVISORS13,748$0 M0.01%0.03%newJun 30, 2026
🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC13,358$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 Dimensional US Core Equity 1 ETFDimensional Fund Advisors LP13,711$0 M0.01%<0.01%+98%Jul 31, 2026
🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc.12,293$0 M0.01%0.01%+23%Jun 30, 2026
🇺🇸 Fidelity Flex Small Cap Index FundFidelity Management & Research Company LLC13,530$0 M0.01%0.01%+2.4%Jul 31, 2026
🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC13,505$0 M0.01%<0.01%no changeJul 31, 2026
🇺🇸 Dimensional US Sustainability Core 1 ETFDimensional Fund Advisors LP12,923$0 M0.01%<0.01%newJul 31, 2026
🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc.11,143$0 M0.01%0.01%no changeJun 30, 2026
🇺🇸 1290 VT Small Cap Value PortfolioEquitable Investment Management Group, LLC10,484$0 M0.01%0.01%+655%Jun 30, 2026
🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC9,893$0 M0.01%<0.01%−79%Jun 30, 2026
🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC9,842$0 M0.01%0.01%no changeJun 30, 2026
🇺🇸 Voya RussellTM Small Cap Index PortfolioVoya Investments, LLC9,808$0 M0.01%0.01%+23%Jun 30, 2026
🇺🇸 AQR Small Cap Momentum Style FundAQR CAPITAL MANAGEMENT, LLC16,645$0 M0.02%0.03%—Mar 31, 2026
🇺🇸 U.S. Social Core Equity 2 PortfolioDimensional Fund Advisors LP9,806$0 M0.01%<0.01%newJul 31, 2026
🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc.9,295$0 M<0.01%<0.01%−3.1%Jul 31, 2026
🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC8,595$0 M<0.01%0.01%no changeJul 31, 2026
🇺🇸 VIP Extended Market Index PortfolioFidelity Management & Research Company LLC7,432$0 M<0.01%<0.01%+35%Jun 30, 2026
🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management6,834$0 M<0.01%0.01%no changeJun 30, 2026
🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION10,000$0 M0.01%<0.01%no changeMay 31, 2026
🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC6,246$0 M<0.01%0.01%−4.2%Jun 30, 2026
🇺🇸 Clearwater Select Equity FundClearwater Management Co Inc.6,076$0 M<0.01%<0.01%−50%Jun 30, 2026
🇺🇸 Dimensional U.S. Equity Market ETFDimensional Fund Advisors LP6,281$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS6,066$0 M<0.01%0.01%no changeJul 31, 2026
🇺🇸 PD Small-Cap Value Index PortfolioPacific Life Fund Advisors LLC5,412$0 M<0.01%0.02%+624%Jun 30, 2026
🇺🇸 Voya VACS Index Series SC PortfolioVoya Investments, LLC5,390$0 M<0.01%0.01%+13%Jun 30, 2026
🇺🇸 Vanguard Russell 2000 Value Index FundThe Vanguard Group, Inc.8,326$0 M<0.01%<0.01%+4.3%May 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 100 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at Rezolute, Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$289 K
10 purchases, 5 insiders
Sold, 12 months
$0
0 sales, 0 insiders
Net, 12 months
$289 K
open market only
Insiders on file
20
since
$5.2 M$0Feb 2024: bought $98 K (7 trades), sold $0 (0 trades)Feb 24Mar 2024: bought $221 K (6 trades), sold $0 (0 trades)May 2024: bought $31 K (5 trades), sold $0 (0 trades)MayJun 2024: bought $5.2 M (7 trades), sold $0 (0 trades)Sep 2024: bought $20 K (1 trades), sold $0 (0 trades)SepDec 2024: bought $84 K (2 trades), sold $0 (0 trades)Feb 2025: bought $47 K (1 trades), sold $0 (0 trades)FebMar 2025: bought $112 K (4 trades), sold $0 (0 trades)Jun 2025: bought $4.0 M (4 trades), sold $0 (0 trades)JunDec 2025: bought $261 K (9 trades), sold $0 (0 trades)Mar 2026: bought $29 K (1 trades), sold $0 (0 trades)Mar
Bought (open market)Sold (open market)Hover a month for the totals
Rezolute, Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Daron EvansCFOGift-16,000——395,400Form 4
filed Daron EvansCFOGiftindirect+4,000——11,000Form 4
filed Daron EvansCFOGiftindirect+4,000——11,000Form 4
filed Sunil Ratilal KarnawatChief Commercial OfficerShares withheld for tax-2,267$4.500$10 K69,275Form 4
filed Daron EvansCFOShares withheld for tax-3,062$4.990$15 K411,400Form 4
filed Nevan C. ElamCEO, DirectorShares withheld for tax-8,004$4.990$40 K605,497Form 4
filed Brian Kenneth RobertsChief Medical OfficerShares withheld for tax-3,062$4.990$15 K293,851Form 4
filed Daron EvansCFOBuy+10,000$2.850$29 K414,462Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: Rezolute, Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
18.5 M
19.2% of shares · 14.93 days to cover
Buybacks, Q2 2024
$0M
Q4 2024
Shares sold short, last 24 reportsAll stocks →

Stock splits: 50-for-1 split

Rezolute, Inc. share buybacks by quarter
Buybacks, quarterFiscalSpent
Q2 2024Q4 2024$0M

Trading halts

  • 2025-12-11 14:32 UTC, code LUDP, resumed 14:37 UTC
  • 2025-12-11 11:55 UTC, code T3, resumed 12:20 UTC

Fails to deliver

  • : 25 shares at $4.11
  • : 25,429 shares at $4.87
  • : 1,800 shares at $4.54
  • : 96 shares at $4.50
  • : 2,340 shares at $5.04

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

Rezolute, Inc. scorecard#

Passes 1 of the 12 checks that could be worked out. Fiscal year 2026; market cap of Oct 28, 2026.

  • Valuation0 of 4
    • ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
    • ✗Price to book below its peers' median4.0×Price to book 4.0× against Biotechnology's median of 2.9×.
    • –Price to sales below its peers' medianNo Price to sales on file.
    • ✗Free cash flow yield above 5%-11.2%Free cash flow is -11.2% of the market value.
    • ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
    • –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
  • Growth0 of 2
    • –Revenue grew in the newest yearRevenue of the year before is not on file.
    • –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
    • –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
    • ✗Earnings per share grew in the newest year-0.75 vs -0.98Diluted EPS -0.75 in fiscal 2026 against -0.98 the year before (report's currency).
    • ✗Net income higher than five years earlier-$78 M-$78 M in fiscal 2026 against -$21 M in 2021.
    • –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
  • Profitability0 of 3
    • ✗Profitable in the newest year-$78 MNet income -$78 M in fiscal 2026.
    • ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2026.
    • –Operating margin above its peers' medianNo operating margin on file.
    • ✗Return on equity above 15%-59.0%-59.0% in fiscal 2026.
    • –Return on invested capital above 10%No return on invested capital on file.
    • –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
  • Financial health1 of 2
    • ✓Short-term assets cover short-term liabilities9.7×Current ratio 9.68 at the end of fiscal 2026.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2026.
    • –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
  • Shareholder returns0 of 1
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✗Share count up no more than 2% in a year36.7%Diluted shares up 36.7% in fiscal 2026.
    • –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
    • –Free cash flow covers dividends and buybacksCash from operations or capital spending is not on file.

Worked out from the statements as filed (sec), the medians of Biotechnology, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Rezolute, Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Rezolute, Inc.: statements by fiscal year
PeriodTrendFY 2026to Jun 30, 2026FY 2025to Jun 30, 2025FY 2024to Jun 30, 2024FY 2023to Jun 30, 2023FY 2022to Jun 30, 2022FY 2021to Jun 30, 2021FY 2020to Jun 30, 2020FY 2019to Jun 30, 2019FY 2018to Jun 30, 2018FY 2017to Jun 30, 2017
Income statement
Research and development546256443215141917r12
General and administrative291815129.47.96.16.9r9.1r8.2
Operating expenses838070564223212629r20
Operating income−83−80−70−56−42−23−21−26−29r−20
Interest and finance income————————0.00
Interest expense and finance costs—————0.405.00.7r0.0
Other non-operating income (expense)—5.52.04.20.82.00.2−4.5−1.1r0.0
Income tax0000000000
Net income including minority interests−78−74−68−52−41−21−20−30——
Minority interests' share of net income———————2.30—
Net income attributable to shareholders−78−74−68−52−41−21−20−30−30r−20
Earnings per share, basic-0.75-0.98-1.33-1.01-2.26-2.72-3.54-18.41r-0.54r-0.57
Earnings per share, diluted-0.75-0.98-1.33-1.01-2.32-2.72-3.54-18.41r-0.54r-0.57
Shares, weighted average (basic)1047651r51187.7————
Shares, weighted average (diluted)1047651r51197.7r0.00.0r0.1r41
Balance sheet
Cash and cash equivalents119470161504177r38r1.6r4.5
Short-term investments97745686——————
Other current assets2.73.31.83.01.70.90.60.60.40.4
Current assets1111711291051524211122.0r4.9
Property, plant and equipment0.00.10.10.10.00.00.00.00.4r5.3
Right-of-use (leased) assets0.81.31.92.10.20.40.40——
Other intangible assets——————00.00.0r0.0
Non-current assets———————0.10.55.7
Total assets1131751331241524311122.5r11
Accounts payable5.05.84.93.31.11.00.90.6r1.9r1.0r
Customer deposits————————0.00.0
Current liabilities11129.65.22.52.03.28.46.2r1.8
Lease liabilities (non-current)0.31.01.71.90.10.20.20——
Non-current liabilities———————2.10.20.3
Total liabilities1213127.52.9173.6116.5r2.1
Retained earnings−481−404−329−261−209−168−147−127−94r−64
Shareholders' equity101162121116149267.41.8−4.0r8.5r
Total liabilities and equity1131751331241524311122.5r11
Shares outstanding968753r37348.45.94.2r0.1r49
Cash-flow statement
Depreciation and amortization0.00.00.00.00.00.00.00.01.1—
Share-based compensation147.17.47.33.74.03.32.65.1r6.0
Cash from operating activities−65−69−57−44−40−20−24−15−14r−13
Capital expenditure———−0.2——0−0.0−0.0—
Cash from investing activities−21−1549−101—000.21.7r−0.2
Debt repaid————−16—————
Shares issued—————02404.5—
Shares bought back——−0.0———————
Cash from financing activities2.210763121495223259.5r14
Change in cash−832454−13410931−1.69.9——
Report10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

Where Rezolute, Inc. operates: 3 countries#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue. 2 subsidiaries on file.

Rezolute, Inc.: countries of operation
CountryPresenceRevenue there
🇺🇸 USAHeadquarters1 office—
🇮🇪 Ireland1 subsidiary—
🇬🇧 UK1 subsidiary—

Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided

Executive pay at Rezolute, Inc.#

From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.

CEO total pay, fiscal 2026
$5.7 M
Nevan Charles Elam
Other top executives, average
$2.5 M
the CEO earned 2.3× this
$100 invested is now
$263
Rezolute, Inc.: executive pay by fiscal year
Fiscal yearCEO total payActually paidOther executives, average$100 invested
2026Nevan Charles Elam$5.7 M$4.1 M$2.5 M$263
2025Nevan C. Elam$2.9 M$2.1 M$1.6 M$225
2024Nevan C. Elam$1.2 M$5.0 M$601 K$217

Source: SEC proxy statement (Form DEF 14A) · as of Jun 30, 2026

Events at Rezolute, Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.

Directors and officers 4 · Material agreement 3 · Agreement ended 1 · Unregistered share sale 2 · Shareholder vote 1 · Results announced 8

Rezolute, Inc.: events reported to the SEC
FiledWhat happenedFiling
Results announced8-K
Results announced8-K
Results announced8-K
Results announced8-K
Shareholder vote8-K
Results announced8-K
Directors and officersMaterial agreementAgreement ended8-K
Results announced8-K
Directors and officersMaterial agreement8-K
Unregistered share sale8-K
Directors and officers8-K/A
Results announced8-K
Material agreementUnregistered share sale8-K
Directors and officers8-K
Results announced8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Nov 5, 2026

Acquisitions and funding#

1 private funding rounds before listing

Private share sales · funding history

Private share sales of Rezolute, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2020$41 MPrivate placement after listing$10 to $50 million12equity, optionsSEC
Jan 2018$5 MPrivate placement after listing$2 to $10 million34debt, optionsSEC
Mar 2017$7 MPrivate placement after listing$2 to $10 million5equitySEC
Jan 2017$3 MPrivate placement after listing$2 to $10 million190equity, optionsSEC
Jun 2016$5 MPrivate placement after listing$2 to $10 million60equity, optionsSEC
Dec 2015$4 MPrivate placement after listing$2 to $10 million11equity, optionsSEC
Mar 2015$2 MPrivate placement after listingUnder $2 million14equity, optionsSEC
Nov 2014$7 MPrivate placement after listing$2 to $10 million73equity, optionsSEC
Mar 2014$9 MPrivate placement after listing$2 to $10 million113equity, optionsSEC
Dec 2013$1 MNo. 1Under $2 million7debt, optionsSEC

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

How Rezolute, Inc. compares in Biotechnology

  • Market cap$398 M · higher than 55% of 726
  • Price / book4.0× · lower than 38% of 534
  • FCF yield-11.2% · higher than 54% of 449

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Rezolute, Inc.🇺🇸$398 M———
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 28, 2026
Annual results:
For year ending June-2026
Balance sheet:
As of June-2026
Employees:
As of June 30, 2026
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research, SEC annual report, GLEIF register; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Rezolute, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Rezolute, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Rezolute, Inc.? Suggest a correction